DUBLIN–(BUSINESS WIRE)–The “3D Cell Cultures: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The report includes:
Whether the discussion is about stem cells, tissue engineering, or microphysiological systems, their vital role in drug discovery, toxicology, and other areas leading to new product development, 3D cell culture is becoming the environment that will increasingly define the basis for future advances.
To mix metaphors, 3D cell culture is also cross-roads through which just about everything else passes on its way to building knowledgebases or introducing new products. This study is needed to bring together and make sense out of the broad body of information encompassed by 3D cell culture.
Three-dimensional cell culture has been used by researchers for many years now, with early adoption and now key roles in cancer and stem cells. Organ-on-a-chip technology, also known as microphysiological systems, is leading to dramatic breakthroughs. Also, stem cell research coupled with synthetic biology is opening new areas. This study is needed to provide a perspective on these advances.
Furthermore, classical toxicology testing programs have been in place for many decades, and over the past 20 years, animal welfare and scientific activities have spurred the development of in vitro testing methods. In silico methods are advancing in novel ways that need to be analyzed and considered in terms of their impacts on cell culture.
This report investigates the recent key technical advances in 3D cell culture equipment, raw materials, assay kits, analytical methods, and clinical research organization (CRO) services. It should also be pointed out that this report takes a somewhat different position on 2D cell culture. It has been criticized for its inadequacies and the misleading information it can produce. However, a review of industry practices makes it clear that it still has its place and will contribute to future advances in unexpected ways.
The company section looks at many of the suppliers who provide equipment, assays, cells, reagents, and services used in 3D cell culture. This study sought to understand business models and market maturity dynamics in greater depth as well as providing more quantitative analysis of their operations.
Key Topics Covered
Chapter 1 Introduction
Chapter 2 Summary
Chapter 3 Highlights and Issues
Chapter 4 Tissue and Cell Culture: Technology and Product Background
Chapter 5 Assays, Imaging and Analysis
Chapter 6 Regulation and Standardization
Chapter 7 3D Models for Cancer
Chapter 8 Landscape for Toxicology and Drug Safety Testing
Chapter 9 Stem Cell Landscape
Chapter 10 Regenerative Medicine: Organ Transplants and Skin Substitutes
Chapter 11 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/htgg5z